TI
KURA icon

Trexquant Investment’s Kura Oncology KURA Stock Holding History

Trexquant Investment’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Sell
183,731
-344,973
-65% -$3.25M 0.01% 1189
2026
Q1 		$4.3M Buy
528,704
+301,322
+133% +$2.59M 0.03% 709
2025
Q4 		$2.36M Buy
227,382
+12,339
+6% +$129K 0.02% 930
2025
Q3 		$1.9M Sell
215,043
-334,718
-61% -$2.39M 0.02% 923
2025
Q2 		$3.17M Sell
549,761
-136,209
-20% -$834K 0.04% 717
2025
Q1 		$4.53M Buy
685,970
+119,025
+21% +$928K 0.05% 545
2024
Q4 		$4.94M Buy
566,945
+508,362
+868% +$7.31M 0.06% 529
2024
Q3 		$1.14M Buy
58,583
+4,519
+8% +$91.6K 0.01% 1009
2024
Q2 		$1.11M Buy
54,064
+35,358
+189% +$727K 0.02% 971
2024
Q1 		$399K Sell
18,706
-45,321
-71% -$881K 0.01% 1217
2023
Q4 		$921K Buy
64,027
+27,312
+74% +$269K 0.02% 852
2023
Q3 		$335K Sell
36,715
-46,608
-56% -$473K 0.01% 1189
2023
Q2 		$882K Buy
+83,323
New +$985K 0.02% 800
2022
Q4 		– Sell
-53,641
Closed -$733K – 1565
2022
Q3 		$733K Buy
53,641
+33,866
+171% +$522K 0.03% 645
2022
Q2 		$362K Buy
+19,775
New +$284K 0.02% 1021
2022
Q1 		– Sell
-13,768
Closed -$193K – 1557
2021
Q4 		$193K Buy
13,768
+1,008
+8% +$16.3K 0.01% 1160
2021
Q3 		$239K Sell
12,760
-11,296
-47% -$213K 0.02% 871
2021
Q2 		$502K Buy
24,056
+16,296
+210% +$405K 0.04% 490
2021
Q1 		$219K Sell
7,760
-14,615
-65% -$462K 0.02% 925
2020
Q4 		$731K Buy
+22,375
New +$786K 0.08% 340
2020
Q3 		– Sell
-17,001
Closed -$277K – 1388
2020
Q2 		$277K Sell
17,001
-14,085
-45% -$203K 0.02% 913
2020
Q1 		$309K Buy
31,086
+18,825
+154% +$215K 0.02% 841
2019
Q4 		$169K Buy
+12,261
New +$182K 0.01% 942
2018
Q4 		– Sell
-12,396
Closed -$217K – 1175
2018
Q3 		$217K Buy
+12,396
New +$238K 0.02% 796

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Trexquant Investment's KURA Position: Q2 2026 in Review

Trexquant Investment reduced its Kura Oncology (KURA) stake by 65% in Q2 2026, selling an estimated $3.25M and leaving 183,731 shares worth $2.02M. The position accounts for 0.01% of the portfolio, ranked #1189.

Trexquant Investment first reported a position in KURA in Q3 2018 and has held it in 24 quarters since. The position peaked at $4.94M in Q4 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Trexquant Investment held 183,731 shares of Kura Oncology worth $2.02M as of Q2 2026.
  • Trexquant Investment sold 344,973 Kura Oncology shares in Q2 2026, an estimated $3.25M.
  • Kura Oncology made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1189 holding.
  • Trexquant Investment first reported a position in Kura Oncology in Q3 2018 and has held it in 24 quarters since.
  • Trexquant Investment's Kura Oncology position peaked at $4.94M in Q4 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.